Author: Guo, Yong; Chen, Yan; Li, Yingchuan
Title: Glucocorticoids Should Be Used With Caution in Patients With SARS-CoV-2 Cord-id: 11o4cw7k Document date: 2021_2_24
ID: 11o4cw7k
Snippet: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global pandemic, and the use of glucocorticoids in clinical practice is controversial. Our clinical experiences with glucocorticoid treatment suggested that, while use was effective in some cases, in other cases, glucocorticoid were ineffective and even resulted in immunosuppression that could lead to deterioration. Therefore, glucocorticoids should be used with caution in patients with SARS-CoV-2.
Document: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global pandemic, and the use of glucocorticoids in clinical practice is controversial. Our clinical experiences with glucocorticoid treatment suggested that, while use was effective in some cases, in other cases, glucocorticoid were ineffective and even resulted in immunosuppression that could lead to deterioration. Therefore, glucocorticoids should be used with caution in patients with SARS-CoV-2.
Search related documents:
Co phrase search for related documents- abdominal pressure and acute phase: 1
- abdominal pressure and acute respiratory syndrome: 1, 2, 3, 4, 5
- abdominal pressure and admission day: 1, 2
- abdominal pressure and lung compliance: 1, 2, 3, 4
- abnormal immune response and acute phase: 1, 2
- abnormal immune response and acute respiratory syndrome: 1, 2, 3, 4, 5
- academician nanshan zhong and acute respiratory syndrome: 1
- acid sample and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute ards respiratory distress syndrome and admission day: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute ards respiratory distress syndrome and admission prior: 1, 2, 3, 4, 5, 6
- acute ards respiratory distress syndrome and long term prognosis: 1
- acute ards respiratory distress syndrome and low moderate: 1, 2, 3, 4, 5
- acute ards respiratory distress syndrome and low moderate dose: 1, 2
- acute ards respiratory distress syndrome and lung compliance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute ards respiratory distress syndrome and lung compliance decrease: 1, 2
- acute ards respiratory distress syndrome and lung extensive inflammation: 1
- acute exacerbation and admission day: 1, 2
- acute exacerbation and long term prognosis: 1
- acute exacerbation and low moderate: 1
Co phrase search for related documents, hyperlinks ordered by date